Skip to content

Clinical trials

Observational Inflammation trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Observational Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20094
20102
20111
20122
20143
20171
20181
20191
20202
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status7
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center5
Maastricht University Medical Center3
Top Institute Pharma3
University Medical Center Groningen2
Erasmus Medical Center1
Gerdien Tramper1
Leiden University Medical Center1
Maastricht University1
Prof. Jan-Willem Lammers MD PhD1
Sint Franciscus Gasthuis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation22
Pulmonary Disease, Chronic Obstructive6
Asthma3
Infections3
COVID-192
Cardiovascular Diseases2
Disease Susceptibility2
Lung Diseases, Interstitial2
Sarcoidosis2
Aortic Valve Disease1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.